DGS Capital Management’s PepsiCo PEP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$567K Buy
3,652
+368
+11% +$57.3K 0.09% 208
2025
Q4
$471K Buy
3,284
+863
+36% +$127K 0.08% 216
2025
Q3
$340K Buy
2,421
+239
+11% +$34.1K 0.06% 255
2025
Q2
$288K Sell
2,182
-165
-7% -$22.2K 0.06% 246
2025
Q1
$352K Sell
2,347
-1,045
-31% -$156K 0.09% 205
2024
Q4
$516K Sell
3,392
-92
-3% -$15.1K 0.13% 149
2024
Q3
$592K Sell
3,484
-20
-0.6% -$3.44K 0.16% 134
2024
Q2
$578K Buy
3,504
+1,211
+53% +$209K 0.16% 121
2024
Q1
$401K Sell
2,293
-60
-3% -$10.1K 0.11% 162
2023
Q4
$400K Sell
2,353
-153
-6% -$25.4K 0.15% 126
2023
Q3
$425K Sell
2,506
-67
-3% -$12.2K 0.21% 111
2023
Q2
$477K Buy
2,573
+1,212
+89% +$226K 0.24% 96
2023
Q1
$248K Sell
1,361
-1
-0.1% -$175 0.14% 166
2022
Q4
$246K Buy
+1,362
New +$243K 0.16% 169
2022
Q2
Sell
-1,286
Closed -$215K 213
2022
Q1
$215K Buy
+1,286
New +$216K 0.13% 163

Other funds holding PEP

DGS Capital Management's PEP Position: Q1 2026 in Review

DGS Capital Management increased its PepsiCo (PEP) stake by 11% in Q1 2026, buying an estimated $57.3K and bringing the position to 3,652 shares worth $567K. The position accounts for 0.09% of the portfolio, ranked #208.

DGS Capital Management first reported a position in PEP in Q1 2022 and has held it in 15 quarters since. The position peaked at $592K in Q3 2024. 3,533 funds tracked by Wall St. Rank hold PEP as of Q1 2026.

  • DGS Capital Management held 3,652 shares of PepsiCo worth $567K as of Q1 2026.
  • DGS Capital Management bought 368 PepsiCo shares in Q1 2026, an estimated $57.3K.
  • PepsiCo made up 0.09% of DGS Capital Management's portfolio in Q1 2026, its #208 holding.
  • DGS Capital Management first reported a position in PepsiCo in Q1 2022 and has held it in 15 quarters since.
  • DGS Capital Management's PepsiCo position peaked at $592K in Q3 2024.
  • 3,533 funds tracked by Wall St. Rank held PepsiCo as of Q1 2026.

Based on DGS Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.